Related Experiment Video
Updated: May 18, 2026

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells
Published on: June 2, 2022
Cadm1 is a metastasis susceptibility gene that suppresses metastasis by modifying tumor interaction with the
Farhoud Faraji1, Yanli Pang, Renard C Walker
1Metastasis Susceptibility Section, Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Abstract:
Metastasis is a complex process utilizing both tumor-cell-autonomous properties and host-derived factors, including cellular immunity. We have previously shown that germline polymorphisms can modify tumor cell metastatic capabilities through cell-autonomous mechanisms. However, how metastasis susceptibility genes interact with the tumor stroma is incompletely understood. Here, we employ a complex genetic screen to identify Cadm1 as a novel modifier of metastasis. We demonstrate that Cadm1 can specifically suppress metastasis without affecting primary tumor growth. Unexpectedly, Cadm1 did not alter tumor-cell-autonomous properties such as proliferation or invasion, but required the host's adaptive immune system to affect metastasis. The metastasis-suppressing effect of Cadm1 was lost in mice lacking T cell-mediated immunity, which was partially phenocopied by depleting CD8(+) T cells in immune-competent mice. Our data show a novel function for Cadm1 in suppressing metastasis by sensitizing tumor cells to immune surveillance mechanisms, and this is the first report of a heritable metastasis susceptibility gene engaging tumor non-autonomous factors.
Insights
Cadherin-1 (Cadm1) suppresses cancer metastasis by enhancing immune surveillance, not by altering tumor cell growth or invasion. This gene requires T cell immunity to function, revealing a link between heritable factors and the immune system in metastasis.
Area of Science:
- Oncology
- Immunology
- Genetics
Background:
- Metastasis involves tumor cell-intrinsic traits and host factors, including immune responses.
- Germline polymorphisms can influence cancer metastasis via cell-autonomous mechanisms.
- The interaction between metastasis susceptibility genes and the tumor microenvironment is not fully understood.
Purpose of the Study:
- To identify novel genes that modify cancer metastasis.
- To investigate the mechanisms by which metastasis susceptibility genes interact with the host.
- To explore the role of Cadherin-1 (Cadm1) in metastasis.
Main Methods:
- A complex genetic screen was used to identify metastasis modifiers.
- Experiments were conducted in mice with varying immune statuses (e.g., T cell deficient).
- Tumor cell proliferation, invasion, and metastasis were assessed, along with CD8(+) T cell activity.
Main Results:
- Cadm1 was identified as a novel suppressor of metastasis, independent of primary tumor growth.
- Cadm1 did not affect tumor cell-autonomous properties like proliferation or invasion.
- Cadm1's metastasis-suppressing function was dependent on T cell-mediated immunity and was lost in T cell-deficient mice.
Conclusions:
- Cadm1 suppresses metastasis by sensitizing tumor cells to immune surveillance.
- This study reveals a novel mechanism where a heritable metastasis susceptibility gene engages non-autonomous, immune-related factors.
- Cadm1 represents a new target for understanding and potentially treating cancer metastasis through immune modulation.
More Related Videos
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Abnormal Proliferation
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Inhibition of Cdk Activity
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Cancer Cell Migration through Invadopodia

